Table 2.
Systemic treatments for psoriasis received by 7354 patients with severe psoriasis*
| Treatment | No (%) |
|---|---|
| Phototherapy† | 1185 (16) |
| Systemic oral: | |
| Any | 6371 (87) |
| Methotrexate | 4956 (67) |
| Azathioprine | 760 (10) |
| Cyclosporine | 733 (10) |
| Oral retinoids‡ | 346 (5) |
| Hydroxyurea | 231 (3) |
| Mycophenolate mofetil | 91 (1) |
| Tacrolimus | 26 (<1) |
| Biologic therapy: | |
| Any | 48 (<1) |
| Etanercept | 23 (<1) |
| Adalimumab | 18 (<1) |
| Infliximab | 7 (<1) |
| Efalizumab | 0 |
| Ustekinumab | 0 |
*Percentages might not total 100 as patients can have received multiple treatments.
†Includes psoralen and ultraviolet therapies.
‡Including acitretin, etretinate.